Faculty Bibliography

BACKGROUND CONTEXT: This study evaluates the necessity of a multi-rod construct to help prevent a pseudarthrosis in ASD surgery of lesser magnitude. Regardless of an interbody at L5/S1, a multi-rod construct does not decrease the risk of developing a pseudarthrosis. If a pseudarthrosis develops in patients who undergo an interbody fusion at L5/S1, it is more likely to occur above the L5/S1 level and the number of rods used does not decrease this risk. PURPOSE: To examine the necessity of IBF and multi-rod use to prevent pseudarthrosis in these lesser magnitude ASD surgeries. STUDY DESIGN/SETTING: Retrospective review of a multicenter database. PATIENT SAMPLE: A total of 483 patients met our inclusion criteria of pelvic fixation, > 2 year follow up, >5 levels fused, no 3-column osteotomy (3CO), and no multi-level interbody fusions. OUTCOME MEASURES: Pseudarthrosis rate and location in ASD patients.
METHOD(S): A multi-center database was evaluated to identify patients with pelvic fixation, > 2 year follow up, >5 levels fused, and no 3-column osteotomy (3CO). We define a lesser magnitude ASD surgery as surgeries that do not include 3CO or multi-level interbody fusions. In this cohort, ASD patients with and without an IBF at L5/S1 were assessed to evaluate if the number of rods had an impact on the pseudarthrosis rate. Pseudarthrosis was determined by intraoperative findings or record review. Fisher's exact tests, univariate and multivariate analysis were used to identify predictors of pseudo.
RESULT(S): A total of 483 patients met our inclusion criteria with an average follow-up of 48 months. Of those, 321 (66%) had interbody at L5/S1 (IBF). Twenty-three percent of IBF patients had a MR construct and 77% had a SR construct. In the non-IBF group, 33% had a MR construct. In the IBF group, the MR construct did not impact the pseudarthrosis rate compared to a SR construct, (6.8% vs 5.2% respectively, p=.35). In the IBF group, 29% (4) of MR patients and 75% (6) of SR patients with pseudo received BMP. However, regardless of the rod construct, ASD patients with an interbody at L5/S1 had an increased risk of having a pseudarthrosis above this level (OR.096, p=.045). Also, the MR construct did not decrease the risk of developing a pseudarthrosis in the non-IBF group (0% vs 4.5%, p=.18).
CONCLUSION(S): In ASD surgery of lesser magnitude, a multi-rod construct does not decrease the risk of developing a pseudarthrosis. Patients who have an interbody fusion at L5/S1 are more likely to develop a pseudarthrosis above this level, regardless of the rod construct. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Frailty is a baseline measure of disability that transcends age alone and has been determined a strong predictor of outcomes following adult spinal deformity (ASD) surgery. This postop impact calls for investigation of unique adjustment of Global Alignment and Proportion (GAP) scores accounting for frailty. This adjustment in spinal proportion may help surgical planning for individualized, optimal postop outcomes. PURPOSE: Modify the GAP score with frailty to optimize outcomes in surgical ASD patients. STUDY DESIGN/SETTING: Retrospective review of a single-surgeon comprehensive ASD database PATIENT SAMPLE: A total of 140 ASD patients OUTCOME MEASURES: Frailty-adjusted GAP scores; Health Related Quality of Life scores (HRQLs): ODI, SRS-22 METHODS: Surgical ASD patients (SVA>=5cm, PT>=25degree, or TK >=60degree, >3 levels fused) >=18 years old with available baseline (BL) radiographic data were isolated in the single-center Comprehensive Spine Quality Database (Quality). Patients were dichotomized by the ASD frailty index, F (Not Frail, Frail). Linear regression analysis established radiographic equations for frailty-adjusted GAP Scores at baseline and 2-years involving relative pelvic version, relative lumbar lordosis, lordosis distribution index, relative spinopelvic alignment, and an age factor to formulate a sagittal plane score. Patients were restratified into frailty-adjusted proportionality groups: Proportional (<5.8), Moderately Disproportional (MD) (5.8-7), Severely Disproportional (SD) (>7). Frailty-adjusted GAP proportionality at 2-years were compared to adjusted-BL to determine whether patients improved, deteriorated or remained the same in their spine proportion.
RESULT(S): A total of 140 patients were included (55.5+/-16.4 yrs, 77.5% female, 25.2+/-4.7 kg/m2). BL frailty: 32.8% not frail, 67.2% frail. Primary analyses demonstrated correlation between BL frailty score and BL and 2-year GAP scores(P<0.001). Linear regression analysis(p<0.001) developed a frailty-adjusted GAP threshold equation: 4.4 + 0.93*(frailty score). Adjusted-baseline scores were taken and re-stratified based distribution and placed 26.4% of patients in Proportional, 26.6% MD, and 44% SD. BL adjusted GAP scores by frailty group: 5.3 Not Frail, 7.5 Frail; p<0.001. At 2-years, GAP scores were grouped into the frailty-adjusted proportionality groups: 66.2% Proportional, 10.8% MD, and 23.1% SD. Patients who were 2-year MD/SD underwent significantly more reoperations (>33.5%) compared to Proportional (12.8%), p=0.015. SD 2-year patients developed increased PJK at the 1-year mark (40%, Proportional: 13.9%, MD:7.1%, p=0.003), as well as had worse 2-year ODI and SRS-22 satisfaction scores(p<0.050). 47.5% improved in GAP (63.4% of frail patients), 12.3% deteriorated, and 40.2% remained in the same proportionality group at 2-year follow up.
CONCLUSION(S): Significant associations exist between frailty and spinal proportion. By adjusting the GAP proportionality groups accounting for baseline frailty contributed to improved outcomes and minimized reoperations. The adjusted GAP groups appeal for less rigorous spine proportion goals in severely frail patients. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: With the rise of health care costs and a focus on value-based outcomes, hospitals have become more cognizant on cost of revisions and complications. However, literature on the effect of distal junctional kyphosis in driving up health care costs is scarce. PURPOSE: To evaluate the effect of distal junctional kyphosis on the cost effectiveness of corrective cervical deformity surgery. STUDY DESIGN/SETTING: Retrospective review of a single surgeon database. PATIENT SAMPLE: This study included 123 cervical deformity patients. OUTCOME MEASURES: Cost per QALY.
METHOD(S): Cervical deformity patients with minimum 1-year HRQL follow-up were included. Means comparison tests assessed differences in baseline demographic and clinical data. Utility data was calculated using published conversion methods to convert NDI to SF-6D. QALYs utilized a 3% discount rate to account for residual decline to life expectancy (78.7 years). Costs was calculated using the PearlDiver database incorporating complications, comorbidities (CC), major complications, and comorbidities (MCC) were assessed according to CMS.gov manual definitions. Reimbursement consisted of a standardized estimate using regression analysis of Medicare pay-scales for all services rendered within a 30-day window, including estimates regarding costs of postoperative complications, outpatient health care encounters, revisions and medical-related readmissions. After accounting for CC, MCC, length of stay (LOS) and death, cost per QALY at 2Y was calculated for revisions due to distal junctional kyphosis.
RESULT(S): A total of 123 cervical deformity patients met inclusion criteria (57.22yrs, 54%F, 29.0kg/m2). At baseline, patients presented radiographically as: PT (16.9+/-9.7), PI (54.7+/-11.4), PI-LL (-2.9+/-12.6), SVA (80.5+/-49.8), cSVA (28.4+/-20.6), TS-CL (26.6+/-14.4). Surgical details: EBL of 708 mL, operative time of 438.6 min, with 29.51% undergoing an anterior approach, 50.82% posterior-only approach, and 19.67% combined approach. Overall, 7.9% of patients developed DJK within two years postoperatively. Average cost of revision surgery due to DJK within 2years of index surgery was $50,736 +/- 31,467. Patients that developed DJK within 2years of index surgery trended toward having a greater baseline NDI (62.8 vs 55.47, p>0.05) and showed less improvement in NDI at 2 years (4 vs 16.6). Overall, cost per QALY was higher for patients developing DJK at 2 years ($28,483 vs $20,989).
CONCLUSION(S): Cervical deformity revisions due to distal junctional kyphosis had a cost per QALY of $28,483. Efforts to limit postoperative DJK after surgical intervention can further limit additional costs associated with revisions and complications. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: For patients with coronary artery disease, the two most common options for intervention are a cardiac stent or a coronary artery bypass graft. Although less invasive, stents may pose a long-term risk for patients undergoing further invasive procedures such as elective spine surgery. This study aimed to provide surgeons with insight on possible major complications for elective spine surgery patients with a history of coronary artery disease. PURPOSE: Investigate outcomes of elective spine fusion patients with prior history of cardiac intervention STUDY DESIGN/SETTING: Retrospective review of the PearlDiver database between the years 2006-2013 PATIENT SAMPLE: A total of 731,173 elective spine fusion patients OUTCOME MEASURES: Comorbidity burden, 30-day and 90-day complications, readmission METHODS: Elective spine fusion patients were isolated with ICD-9 and CPT procedures codes in the PearlDiver database. Patients were stratified by having previous history of a coronary stent (Stent), coronary artery bypass graft (CABG), and no previous heart procedure (No-HP). Means comparison tests (chi-squared and independent samples t-tests, as appropriate) compared differences in demographics, diagnoses, and comorbidities. Logistic regression assessed the odds of 30-day and 90-day postoperative (postop) complications associated with each heart procedure (Odds Ratio [95% confidence interval]). Statistical significance was set p<0.05.
RESULT(S): A total of 731,173 elective spine fusion patients were included. Overall, 8,401 pts underwent a CABG, 24,037 patients Stent, and 698,735 had No-HP prior to spine fusion surgery. Compared to Stent and No-HP patients, CABG patients had higher rates of morbid obesity, chronic kidney disease and diabetes (p<0.001 for all). Stent patients had higher rates of peripheral vascular disease, hypertension, and hyperlipidemia (all p<0.001). Within 30 days postoperatively of index surgery, CABG patients had significantly higher complication rates including pneumonia, cerebrovascular accident (CVA), myocardial infarction (MI), sepsis, and death compared to No-HP (all p<0.001). Stent patients vs No-HF also had higher 30-day postoperative complication rates including pneumonia, CVA, MI, sepsis, and death. Adjusting for age, comorbidities and sex, Stent was significantly predictive of a MI 30-days post-op (OR: 1.90 [1.53-2.34], P<0.001). Additionally, Stent patients compared to CABG patients had 1.99x greater odds of a MI within 30-days (OR: 1.99 [1.26-3.31], p=0.005) and 2.02x greater odds of readmission within 90-days postop (OR: 2.2 [1.53-2.71, p<0.001).
CONCLUSION(S): With regards to spine surgery, coronary artery bypass graft remains the gold standard for risk reduction. Stenting does not appear to minimize risk as significantly as CABG. When assessing patients with a history of coronary artery disease for elective spine fusion surgery, surgeons should be cautious of the significant risk of major complications associated with stents compared to coronary artery bypass grafting. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Surgical intervention of the cervical spine is a challenging procedure that can present postoperative complications such as dysphagia, swelling, and reoperations. However, the risk of reoperation can possibly be mitigated with the use of biologics to enhance fusion. There is paucity in the literature on long-term incidence of reoperations after application of BMP during ACDF. PURPOSE: To evaluate if bone morphogenetic protein usage during anterior cervical discectomy and fusion will decrease reoperation rates. STUDY DESIGN/SETTING: Retrospective review of the PearlDiver database between 2006-2014. PATIENT SAMPLE: Matched cohort of 35,544 ACDF patients. OUTCOME MEASURES: Reoperations.
METHOD(S): Patients undergoing an anterior cervical discectomy and fusion between the years 2006-2014 were isolated in the PearlDiver database. Patients receiving BMP operatively and a control with no BMP were matched for baseline demographics including age, sex, and comorbidities. A Kaplan Meier Survival analysis assessed five-Year Reoperation-Free Survival between BMP patients and controls. Statistical significance was set to p<0.05.
RESULT(S): A matched cohort of 35,544 ACDF patients was isolated. A total of 17,772 patients received BMP while undergoing cervical fusion and 17,772 did not receive any BMP during surgery. Patients did not differ in age, sex or comorbidities (p>0.05). Kaplan Meier survival analysis showed patients receiving BMP during cervical fusion were significantly more likely to remain reoperation free five years after index surgery (p<0.05). Overall, 91.3% of BMP patients remained reoperation free at five years.
CONCLUSION(S): For patients receiving bone morphogenetic protein during anterior cervical discectomy and fusion, Kaplan-Meier survival analysis following five years post index surgery had showed a 91.3% reoperation-free survivorship. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: AI algorithms have shown substantial promise in medical image analysis. Previous studies of ASD clusters have analyzed alignment metrics - this study sought to complement these efforts by analyzing images of anatomical landmarks. PURPOSE: We hypothesized that a neural-network-based artificial intelligence (AI) algorithm would cluster preoperative lateral radiographs of into groups with distinct morphology. STUDY DESIGN/SETTING: Retrospective cohort study. PATIENT SAMPLE: A total of 915 patients with adult spinal deformity and preoperative lateral radiographs. OUTCOME MEASURES: Schwab modifiers for SVA and PI-LL, three-column osteotomy, upper instrumented vertebrae, baseline Oswestry Disability Index, and 2-year likelihood of reaching MCID in ODI (set at -12.8). Proximal junctional kyphosis and proximal junctional failure were defined using previously published radiographic criteria.
METHOD(S): Vertebral locations for C3-L5, sacral endplate, and femoral heads were measured on lateral radiographs. Pixel locations were used to create a black-and-white overlay to the image, which was subsequently standardized for size and position using the femoral heads and sacral endplate. These images were used to train a self-organizing map (SOM). SOMs are a form of artificial neural network frequently employed in unsupervised classification tasks.
RESULT(S): In total, 915 preoperative lateral radiographs were analyzed. A 2 x 3, toroidal SOM was trained. The mean spine shape was plotted for each cluster. Alignment, surgical characteristics, and outcomes were compared between clusters. Clusters C and D exhibited a particularly high proportion of patients with optimal (ie, modifier 0) values of PI-LL (65.0% and 68.5%) and SVA (72.8% and 53.1%). Conversely, clusters B, E, and F tended to have poor (ie, modifier ++) PI-LL (74.8%, 66.9%, and 74.6%) and SVA (75.5%, 48.6%, and 58.7%). 3-CO was most common among cluster A (26.8%), cluster B (32.6%), and cluster F (32.7%). UIV at T7-T12 was most common among cluster B (51.1%) and cluster F (60.3%). ODI <30 was most prevalent among cluster D (31.4%). There was little difference, however, between groups in likelihood of reaching MCID in ODI at 2-year follow-up. PJK and PJF were particularly prevalent among clusters A (51.2% and 15.5%) and E (50.4% and 18.7%).
CONCLUSION(S): This study developed a self-organizing map that clustered preoperative lateral radiographs of ASD patients into groups with highly distinct overall spinal morphology. These clusters predicted alignment, surgical characteristics, and HRQOL. Further studies of this classification approach will expand to compare pre- and postoperative radiographs. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Many different risk factors for PJK have been identified in those having surgery for ASD. The presence of CF prior to thoracolumbar fusion as a risk factor in this patient population has not been investigated. PURPOSE: To investigate if prior cervical fusion would be a risk factor for PJK when upper thoracic UIV was selected. STUDY DESIGN/SETTING: Retrospective review of prospective multicenter database. PATIENT SAMPLE: Inclusion: age >18 and one of the following inclusion criteria was queried: PI-LL >10, PT >20, Max Cobb>10, SVA > 5 cm. OUTCOME MEASURES: Development of PJK; HRQOL include NRS back and leg, ODI, SRS-22, EQ5D METHODS: Inclusion: age >18 and one of the following inclusion criteria was queried: PI-LL >10, PT >20, Max Cobb>10, SVA > 5 cm. 1023 patients were identified and grouped as CF (prior CF; n=101) and NoCF (n=922). Patients with 5 or fewer levels of CF and those without further cervical spine surgery at final follow-up were included (cASD= 86; ASD= 910). After initial analysis propensity matching was performed controlling for: age, BMI, pre-op alignment (PI, PI-LL, TPA, SVA), change in alignment (PI-LL), and UIV/LIV.
RESULT(S): Among 996 patients the CF group was older (64 v 60; p<0.000), higher BMI (29.7 v 28; p<0.014), with equal gender distribution. PJK at 1 year was 34.9% (n=30) in CF and 34.7% (n=316) in NoCF. All patients included had a minimum of four segments unfused between CF and TL fusion. No differences were found between groups when stratifying by UIV (UT=upper thoracic; LT=Lower thoracic; L=lumbar). Radiographically CF had worse preop deformity (PI-LL 21.3 v 17.2; TPA 27.3 v 23.6; SVA 90.6 v 68.5; p<0.05), with no difference in postop alignment between groups. CF was more likely to have LT UIV (61.6% v 46%; p=0.045) and fusion to the ilium (93% v 81%; p=0.005). After propensity matching 79 patients were included in each group. CF had 68 patients with ACDF, 5 patients with PSF, and 6 patients with A/PSF. There was no difference in the rate of PJK (39.2 v 34.2%), PJK magnitude (13.4 v 13.7) or change in PJK angle (10.1 v 10.4). PJK rate and magnitude are not different by UT or LT as UIV.
CONCLUSION(S): The presence of CF is not associated with the development of PJK or PJK magnitude in this propensity matched cohort. All CF patients had a minimum of four segments unfused between the CF and the TL fusion which may act as a buffer and be protective of PJK. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Complications occur commonly following adult spinal deformity surgery. Length of stay may be influenced by the type of surgical intervention, and/or by postoperative complication and the intervention required to treat that complication. PURPOSE: To understand the impact of complications and their intervention severity on the incremental increase in length of stay. STUDY DESIGN/SETTING: Retrospective cohort study of prospective ASD database. PATIENT SAMPLE: The study included 1418 adult spinal deformity patients. OUTCOME MEASURES: Neurologic complications, HRQL scores.
METHOD(S): ASD patients (>18yrs, scoliosis >=20degree, SVA >=5cm, PT >=25degree and/or TK >60degree). Complications were classified based on complication type, and intervention severity (grade 0, no intervention, Grade 1 minimal intervention (medication change, etc), Grade 2 moderate (cardioversion, chest tube, etc), grade 3 major intervention (return to OR).
RESULT(S): Of the 1418 patients included, 901 had at least one complication event, with 568 with a complication before discharge. Three hundred and six had an event that required a reoperation and 275 were readmitted for their event. When determining LOS, a baseline was established that was influenced by the type of surgery and placed into three groups based on osteotomy (O) and interbody use (I); Group 1 (n408): 0% O, 75% I, LOS=7.9, Group 2 (n374): 100% O, 0% I, LOS=11.9, Group 3 (n595) 100% O and I, LOS=11.2. Having a complication event prior to discharge led to an increase of 1-4 days for each group (p<0.01). This was true for every complication, regardless of type, but was worse for renal and pneumonia. The increase in LOS was most driven by the intervention required. No intervention had an LOS of 6.9, Grade 1 +1.2 days, Grade 2, +1.8 days, Grade 3 +2.5 days. Using the sum of a weighted intervention score (SUM=1*#grade1 + 2*#grade2 + 3*#grade3), we can even more accurately predict the incremental increase in LOS. This occurs until a weighted score of 7 which accurately predicts an increase of 7.5 days.
CONCLUSION(S): Length of stay following ASD is predicted by the type of surgical intervention, and postoperative complication profile. Additional days are most predicted by the type of complication and by intervention severity. A weighted intervention score can predict the additional LOS and is useful to help understand the impact of complications. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: While neurological complications are known to occur following cervical fusions, few studies with sufficient power have quantified the difference in neurological outcomes as posterior cervical fusion (PCF) surgical invasiveness increases. PURPOSE: Compare longer vs shorter PCF complication rates. STUDY DESIGN/SETTING: Retrospective review of the New York State Statewide Planning and Research Cooperative System (SPARCS) database. PATIENT SAMPLE: All patients undergoing >=2 level PCF. OUTCOME MEASURES: Ninety-day neurological or medical complications status post short-cervical (SC), long-cervical (LC), or long cervicothoracic (LCT).
METHOD(S): From the NYS Statewide Planning and Research Cooperative System (SPARCS) database, retrospective review of all patients who underwent >=2 level PCF from 2009-13 with <= 90-day follow-up were identified and stratified by levels fused: 2-3 (SC), 4-8 (LC), and >= 9 (LCT). Data on demographics, hospital-related parameters, and 90-day neurological and other complications, readmissions, and revisions were collected. Regression analysis identified independent predictors of neurologic and overall complications.
RESULT(S): A total of 6,981 patients were included (SC, n=2,964, LC, n=3,899, LCT, n=118). LC patients were older than SC and LCT (60.8 vs 58.2 and 56.1), while LCT patients were more often female (59.3% vs LC 42.1% and SC 44%) and had higher total charges ($187,996 vs LC $99,020 and SC $82,239) and LOS (12.4 vs 6.1 and 6.9 days), all p<0.001. LC had the highest C5-C7 nerve palsy and overall neurological complication rates compared to SC and LCT patients (3.3 vs 1.8 and 1.7%, p=0.001; 3.8 vs 2.3 and 2.5%, p<0.001). Adverse events of the phrenic and recurrent laryngeal nerve were comparable. Implant infection (0.2 vs 0.3 vs 3.4%), and total complication rates (20.3 vs 23.7 vs 42.4%) increased with the number levels fused SC, LC, and LCT respectively, p<=0.017. 90-day readmissions and revisions were comparable. Only LC was a predictor of sustaining 90-day neurological complication (OR=1.7), while both LCT and LC predicted 90-day medical (OR=3.5, 1.3) and total complications (OR=2.7, 1.2), respectively, p<=0.008.
CONCLUSION(S): Compared to 2-3 levels, longer PCF had higher C5-C7 nerve palsy rates (3.3%) and 70% increased odds of sustaining >=1 neurological complication. Longer PCF was also associated with increased rates of medical and total complications. This data can improve the ability to counsel patients regarding the risks and expectations of potential adverse outcomes preceding cervical fusion via posterior or combined anterior-posterior approach. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Scoliosis is frequently associated with Chiari malformation (CM). More specifically, reports have been made about this association with CM-1 in the absence of syrinx status. There is paucity in literature in the surgical risks associated with concurrent CM types and scoliosis diagnosis. PURPOSE: To identify the risks adolescent patients have when diagnosed with CM and scoliosis. STUDY DESIGN/SETTING: Adolescents in pts in Kids' Inpatient Database (KID) during the years of 2003-2012. PATIENT SAMPLE: A total of 35,073 Chiarim pts. OUTCOME MEASURES: Complications.
METHOD(S): CM and scoliosis pts were isolated in KID from 2003-2012. The patients were stratified into three groups: those with concomitant CM and scoliosis (CmS), those with only CM (OCm), and those with only scoliosis (Scol). Demographics, incidence, comorbidity profiles, surgical strategy, and postoperative complications were assessed. Comorbidity profiles were stratified by body systems (neurological, musculoskeletal, pulmonary, cardiovascular, renal). Groups were compared using t-tests and chi-squared tests for continuous and discrete variables, respectively. Multivariate logistic regressions were used to assess association between surgical characteristics/diagnosis with complication rate.
RESULT(S): Included 90,707 spine pts, 63.3% Scol, 38.7%Ocm, and 2.0%Cms. Scol were older (13.6yrs vs CM: 5.9 vs Both:10.9) and had a higher invasiveness score (2.4 vs OCm: 0.5 vs Both:1.5), while CmS pts were more comorbid (0.9 vs OCm: 0.55 vs Scol: 0.89; all p<0.001). CmS pts had higher rates of surgical decompression (25.4%) and Scol pts had higher rates of fusions (35.3%) and osteotomies (1.2%; all p<0.001). However, CmS pts had the highest surgical rate (37.1% vs Scol: 36.6% vs OCm:10.6%) among the cohort (p<0.001). Controlling for age and invasiveness, Scol pts receiving a fusion (1.8[1.08-3.2] operation were associated with development of postoperative complications as well as OCm osteotomies (2.9[1.4-6.0]) and fusions (1.8[1.2-2.9]), and CmS fusion surgeries (1.8[1.0-3.2]; all p<0.05). Having a complication of acute respiratory distress (2.1[3.4-1.3]) and anemia (0.6[0.85-0.36]) were independently associated with CmS operation (all p<0.05).
CONCLUSION(S): Having concurrent scoliosis and Chiari malformation increases operative risk for when decompressive surgeries are performed. Being independently inflicted with scoliosis or Chiari leads to increased complication rate when paired with fusion surgeries. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright